Imexpharm Corporation (HOSE: IMP)
Health Care · Pharmaceuticals · VN
₫37,650.00
+1.48% today · -28.6% 1Y
Imexpharm Corporation (HOSE: IMP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $222.01M.
Over the last twelve months the share price has lost 28.6%, trading between 32.65K and 57.00K.
Tweenvest scores Imexpharm Corporation across four factors: quality 83/100, value 68/100, growth 54/100, dividend 27/100. Its strongest factor is quality.
IMP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $222.01M
- Revenue (TTM)
- $88.25M
- P/E
- 18.45
- EPS
- 2,041.17
- Dividend yield
- 1.33%
- Beta (5Y)
- 0.41
- 52-week high
- ₫57,000.00
- 52-week low
- ₫32,650.00
- Avg volume (3M)
- —
- Shares outstanding
- 154.01M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.